MD Anderson Cancer Center

@mdandersonnews

MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer. Appointments available: 1-877-632-6789

+ Follow

dharmesh

@dharmesh

Co-founder/CTO, HubSpot. Mission: Help millions grow better. Write articles about startups, scaleups and growth at ConnectingDots.com (free subscription).

+ Follow

San Diego Biotech Networks

@sdbn

San Diego Biotech Networks: Building a community and providing #lifescience news, jobs, events. Founding org of @BiotechNetworks. For jobs follow @sdbnjobs.

+ Follow

Biotechnology Innovation Organization

@iambiotech

I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

+ Follow

Publicis Sapient

@publicissapient

Community News | Tech Consulting | Tweets about #DigitalBusinessTransformation in 280 characters or less ⭕️ | Tweet us @PublicisSapient

+ Follow

Rare Disease Day

@rarediseaseday

29 February 2024 is Rare Disease Day. Raising awareness for patients, families and carers around the world that are affected by rare diseases. #RareDiseaseDay

+ Follow

Sabine VanderLinden

@sabinevdl

🔮 Activate Innovation Ecosystems | 🚀 CEO alchemycrew.ventures |🎙 Top 10 Podcast #ScoutingforGrowth |💡Tech Ambassador | #Tech #AI #WomeninTech #FoW

+ Follow

National Cancer Institute

@thenci

The U.S. government’s agency for cancer research. Part of @NIH. Engagement ≠ endorsement. cancer.gov/policies/priva…

+ Follow

Nature Biotechnology

@naturebiotech

Publishing the best of biotech science and business. Part of @SpringerNature and @NaturePortfolio. Find us on Bluesky, Facebook & Instagram.

+ Follow

The Carlyle Group

@onecarlyle

Official account of Carlyle—a global investment firm with deep industry expertise. carlyle.com

+ Follow

Richard van der Blom

@richardvdblom

✪ the truth is not what you see, but what is to be seen✪

+ Follow

Global Genes

@globalgenes

Empowering the Next Generation Rare Disease Advocate. Merged with RARE-X Dec. 2022. #CareAboutRare

+ Follow

Darren Kelly

@djk70

MD/Founder Certa Tx and Chair of Occurx. Biotech. Drug developer. Prof, Unimelb. Entrepreneur, Venture Partner (MRCF), Mentor. Commercial Pilot.

+ Follow

CDC

@cdcgov

CDC's official source for daily credible health & safety updates from Centers for Disease Control & Prevention. Privacy/comment policy: bit.ly/2MhQ6Hp

+ Follow

AlbionVC

@albionvc

We support visionary founders with long-term capital and scale-up expertise. Partners to UK early-stage B2B software and healthcare leaders.

+ Follow

Novo Nordisk

@novonordisk

We're dedicated to championing long-term health. Stay tuned for news and the latest in innovation 💙 #DrivingChange Community guide 👇

+ Follow

U.S. FDA

@us_fda

Our posts are FDA Approved! Privacy Policy - go.usa.gov/xFfG8 FDA Authentic Accounts - bit.ly/FDASocial

+ Follow

Mike Ward

@biopharmamike

Commentating on issues consequential to pharma, biotech, healthcare & medtech stakeholders

+ Follow

[iito] Life Science

@iitolifescience

Worldwide Mass Spectrometry & Transatlantic Life Science Business News Mass-Spec-Capital.com, Life-Sciences-Europe.com, Life-Sciences-USA.com

+ Follow

Nabiha Saklayen

@nabsicle

On my mind: cell & tissue replacements for ALL. CEO @CellinoBio. Recovering physicist @Harvard. STEM fan @Iamastem. global innovator @wef

+ Follow

Dr Ianis G. Matsoukas

@thisisianis

Executive Director | Bridging #Innovation, #Edu & #Business | ExecEdu @Wharton @HarvardMed | PostDoc @ETH-Zurich @WarwickUni @Cornell | PhD @WarwickUni | #TEDx

+ Follow

Sarah

@serahci

PhD in molecular biology & genetics - Amateur astronomer

+ Follow

Molecular Health

@molecularhealth

Committed to translating the information of genes that doctors & patients can make informed decisions about cancer care. Our netiquette rules bit.ly/3zni3bz

+ Follow

NBS System

@nbs_system

NBS System, filiale du groupe CELESTE, est votre référent en matière de Cybersécurité. Ensemble, rendons le monde numérique plus sûr ! #cybersecu #experts

+ Follow

Simon Goldman

@goldie_oz

@AlbionVC partner, helping to turn innovation into global impact @ucltf @ucl. Avid mountaineer, scientist, economist @QueensCam & musician.

+ Follow

La Gazette du LABORATOIRE

@gazettelabo

La Gazette du LABORATOIRE - journal dédié à l'#actualité du monde du #laboratoire et des #sciences 🧪🔬 #gazettelabo

+ Follow

Inpart

@in_part

An online platform for scientific partnering helping take discoveries from bench to bedside.

+ Follow

Pink Sheet, Citeline Regulatory

@pharmapinksheet

Pink Sheet delivers analysis & commentary focused on regulatory implications, including high value perspectives from insiders & thought leaders across the globe

+ Follow

Twist Bioscience

@twistbioscience

Synthetic DNA for Health & Sustainability #WeMakeDNA #TwistBlog #WritingTheFuture #TwistBiopharma #ScienceDoesntStop #DiversityIsInOurDNA

+ Follow

J&J Innovative Medicine EMEA

@jnjinnovmedemea

We are Johnson & Johnson Innovative Medicine EMEA. We innovate with purpose to lead where medicine is going. Our community guidelines: brnw.ch/21wNXHP

+ Follow

Big4Bio

@big4bio

Subscribe FREE for daily biohub news covering the Boston, San Diego, San Francisco, Philadelphia, Los Angeles, New York City, Capital Region, and Seattle areas.

+ Follow

Alex Stockham

@ohpined

🌦️ A big fan of the atmosphere. In the early day of working on a weather blog. Content & marketing lead at Inpart.

+ Follow

Healx

@healx

AI-powered and patient-inspired. We accelerate the discovery and development of #raredisease treatments.

+ Follow

Jonathan Smith

@j_ivories

Reporter for @labiotech_eu. #Data visualisation and #locust nerd. Language learner. #scififantasy fan, #scicomm #PhD

+ Follow

Welcome to the Jungle France

@wttj_fr

Welcome to the Jungle offre des solutions pour rendre le travail excitant et durable.

+ Follow

Endpoints News

@endpts

The biopharma world is here. Get the industry’s most comprehensive daily news reports at endpts.com/subscribe

+ Follow

Juliette

@julaubry

Sales & Customer Success @inova_io Passionate about #Biopharma #partnering #biotech

+ Follow

Mackensie Vernetti

@mackensieverne1

VP, Partnering at Biotechnology Innovation Organization (BIO). Tweets are my own.

+ Follow

Dreamdata - Connect B2B Marketing to Revenue

@dreamdataio

Dreamdata: B2B Activation and Attribution

+ Follow

TME Pharma

@tme_pharma

TME Pharma's #Spiegelmer platform has generated a pipeline of cancer compounds targeting the tumor microenvironment (TME). TME Pharma is listed on Euronext.

+ Follow

Viva Technology

@vivatech

#VivaTech is Europe’s biggest startup & tech event 📍Paris: June 11-14, 2025 💡Daily fix of tech & startup news, insights & innovations!

+ Follow

North Carolina Biotech Networks

@ncbionetworks

Life science news, jobs and events from #NorthCarolina and #SouthCarolina including #Raleigh #Durham. Part of @BiotechNetworks, connecting #biotech since 2008.

+ Follow

Leaps by Bayer

@leapsbybayer

Breaking through the impossible in the life sciences. Leaps by Bayer aims to conquer 10 huge challenges facing humanity.

+ Follow

TScan Therapeutics

@tscan_tx

Harnessing novel T cell systems to extend the promise of immunotherapy! #TScan #CellTherapy #UnleashImmunity

+ Follow

Cellino

@cellinobio

Building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies.

+ Follow

BiopharmaTrend

@biopharmatrend

Your go-to resource for news, trends, and analysis of the cutting-edge advances in pharma, biotech and healthcare.

+ Follow

Jazz Pharmaceuticals

@jazzpharma

We’re a global biopharma company developing life-changing medicines for people with limited or no options. Please see our social guidelines - u.nu/cqmf

+ Follow

BridgeBio Pharma

@bridgebiopharma

Hope Through Rigorous Science Our mission is to discover, create, test and deliver transformative medicines to treat patients with genetic diseases. $BBIO

+ Follow

F-star, an invoX Company

@fstar_inc

A clinical-stage biopharma company developing next generation bispecific antibodies to transform the lives of patients with cancer and other serious diseases.

+ Follow

@KyowaKirin_US

@kyowakirin_us

Kyowa Kirin North America is a specialty pharma company dedicated to making a #profoundimpact on patient lives. Community guidelines: bit.ly/kkna135

+ Follow

Molecure

@molecure_sa

Polish innovative biotech company specializing in research and development of innovative small molecule drugs for treatment of respiratory diseases and cancer.

+ Follow

AMR Action Fund

@amractionfund

We are a groundbreaking venture fund investing approximately US$1 billion to bring 2 to 4 new antimicrobials to patients by the end of the decade.

+ Follow